Tours of the Incubator

Arrive before the programing to take a quick tour of the Incubator @ CBLS.

Welcome Remarks

Welcome remarks from NewYorkBIO's CEO, Jennifer Hawks Bland

Intro to the Incubator @ CBLS

Learn about the Incubator @ CBLS and the great work being done by the team at University of Buffalo.

Vision Talk: "New strategies to improve the safety and efficacy of anti-cancer antibodies and antibody-drug conjugates"
Dr. Joseph Balthasar

A TED style talk from an industry professional.

  • Dr. Joseph Balthasar (David and Jane Chu Endowed Chair in Drug Discovery and Development Director of the Center for Protein Therapeutics Executive Director, University Research Initiatives Co-founder and President at Abceutics Inc.)

    Dr. Joseph Balthasar

    David and Jane Chu Endowed Chair in Drug Discovery and Development Director of the Center for Protein Therapeutics Executive Director, University Research Initiatives Co-founder and President at Abceutics Inc.
Panel Discussion: Bench to Bedside
Break

Networking Break

Vision Talk

A TED style talk from an industry professional.

Panel Discussion: Financing the Next Generation of Oncology Companies

Today’s biotech companies face additional market hurdles when accessing capital. Therefore, to fund treatments and cures, especially in areas outside the traditional home bases of venture and investors, companies must be creative. This panel discussion, will examine the challenges and opportunities of accessing capital via traditional routes, partnerships and grants in the context of today’s evolving market through the unique lens of emerging biotech companies.

Vision Talk

A TED Style talk from an industry professional.

Panel Discussion: Patients and Policy

Policymakers consider several different angles when crafting legislation that often has a broad impact on patients, our healthcare system, and the companies in the oncology space. While there are several factors that contribute to the value of a particular therapy or intervention, a patient’s lived experience can make a lasting impact on an elected official or policy maker. The panel will discuss potential ways to impact change and move the needle on policy issues facing the oncology industry over the coming decade.

Closing Remarks

Closing remarks from NewYorkBIO CEO, Jennifer Hawks Bland.

Networking Reception

Join us for cocktails and passed hors d'oeuvres